Drug Pipeline

ALA Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
3
Recruiting
7
Top Sponsors
Active Studies by Phase
Phase 2
4
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07564479 Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity Cisplatin Nephrotoxicity Recruiting
NCT06907485 A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in… Pediatric Brain Tumor Not Yet Recruiting
NCT05020912 Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic… Basal Cell Carcinoma Active, Not Recruiting
NCT05713799 Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With… Insulin Resistance Not Yet Recruiting
Phase 1/2
NCT06307548 Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for… Locally Advanced Colorectal Carcinoma Recruiting
Phase 1
NCT06623201 Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas Basal Cell Carcinoma (BCC) Recruiting
Not specified
NCT06777511 Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated… Amputation Not Yet Recruiting
Sponsors Running ALA Trials
Disease Areas
Get alerts when ALA trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free